Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
American Journal of Hypertension(1)
Global Heart(1)
Journal of the American College of Cardiology(1)
New England Journal of Medicine(1)
The Lancet(1)
Association of urinary sodium excretion with blood pressure and cardiovascular clinical events in 17,033 Latin americans
ArticleAbstract: BACKGROUND Information on actual sodium intake and its relationships with blood pressure (BP) and clPalabras claves:Blood pressure, Cardiovascular disease, Hypertension, Mortality , Sodium intakeAutores:Avezum A.J., Camacho-López P.A., DIaz R., Lamelas P.M., Lanas F., Mente A., Oliveira G.B.F., Orlandini A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Seron P., Teo K.K., Yusuf S.Fuentes:googlescopusA community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial
ArticleAbstract: Background: Hypertension is the leading cause of cardiovascular disease globally. Despite proven benPalabras claves:Autores:Attaran A., Bangdiwala S.I., Camacho-López P.A., Islam S., Lamelas P.M., Majid F.A., McCready T., Mckee M., PATRICIO LOPEZ -JARAMILLO, Schwalm J.D.R., Thabane L., Yusoff K., Yusuf S.Fuentes:googlescopusDevelopment, Testing, and Implementation of a Training Curriculum for Nonphysician Health Workers to Reduce Cardiovascular Disease
ArticleAbstract: Background: Cardiovascular disease (CVD) is the leading cause of death worldwide. The need to addresPalabras claves:Autores:Garis L., Khan M.U., Lamelas P.M., López-López J.P., Majid F.A., McCready T., Musa H., Ng E., Ng K.K., Nieuwlaat R., Onuma O., PATRICIO LOPEZ -JARAMILLO, Paty J., Schwalm J.D.R., Yusoff K., Yusuf S.Fuentes:googlescopusGlobal Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review
ReviewAbstract: The authors developed a global chronic total occlusion crossing algorithm following 10 steps: 1) duaPalabras claves:chronic total occlusion, global, percutaneous coronary intervention, treatment algorithmAutores:Alaswad K., Andres Navarro, Araya M., Avran A., Azzalini L., Babunashvili A.M., Bayani B., Behnes M., Bhindi R., Boudou N., Boukhris M., Bozinovic N.Z., Brilakis E.S., Bryniarski L., Bufe A., Buller C.E., Burke M.N., Buttner A., Cardoso P., Carlino M., Chen J.Y., Christiansen E.H., Colombo A., Croce K., de los Santos F.D., de Martini T., Dens J., di Mario C., Dou K., Egred M., Elbarouni B., ElGuindy A.M., Escaned J., Furkalo S., Gagnor A., Galassi A.R., Garbo R., Gasparini G., Ge J., Ge L., Goel P.K., Goktekin O., Gonzalo N., Grancini L., Hall A., Hanna Quesada F.L., Hanratty C., Harb S., Harding S.A., Hatem R., Henriques J.P.S., Hildick-Smith D., Hill J.M., Hoye A., Jaber W., Jaffer F.A., Jang Y., Jussila R., Kalnins A., Kalyanasundaram A., Kandzari D.E., Kao H.L., Karmpaliotis D., Kassem H.H., Khatri J., Knaapen P., Kornowski R., Krestyaninov O., Kumar A.V.G., Lamelas P.M., Lee S.W., Lefevre T., Leung R., Li Y., Lim S.T., Lo S., Lombardi W., Maran A., Mashayekhi K., McEntegart M., Moses J., Munawar M., Ngo H.M., Nicholson W., Oksnes A., Olivecrona G.K., Padilla L., Patel M., Pershad A., Postu M., Prakasa Rao V.S., Qian J., Quadros A., Rafeh N.A., Råmunddal T., Reifart N., Riley R.F., Tsuchikane E., Wu E.B.Fuentes:scopusMortality and cardiovascular and respiratory morbidity in individuals with impaired FEV <inf>1</inf> (PURE): an international, community-based cohort study
ArticleAbstract: Background: The associations between the extent of forced expiratory volume in 1 s (FEV 1 ) impairmePalabras claves:Autores:Avezum A.J., Bahonar A., Chifamba J., Dagenais G.R., du Plessis J.L., Duong M.L., Gupta R., Igumbor E.U., Iqbal R., Islam S., Karsidag K., Killian K., Kumar R., Kurmi O.P., Lamelas P.M., Lanas F.T., Lear S.A., Leong D.P., Li W., Lu Y., Mohan V., Mony P.K., Nair S., Noorhassim I., O'Byrne P.M., PATRICIO LOPEZ -JARAMILLO, Rahman O., Rangarajan S., Rosengren A., Teo K.K., Wielgosz A., Yan R., Yusoff K., Yusuf S., Yusufali A.M., Zatońska K., Zhi F.Fuentes:googlescopusRivaroxaban with or without aspirin in stable cardiovascular disease
ArticleAbstract: BACKGROUND: We evaluated whether rivaroxaban alone or in combination with aspirin would be more effePalabras claves:Autores:Aboyans V., Alings M., Anand S.S., Avezum A.J., Bangdiwala S.I., Bhagirath V., Bhatt D.L., Bogaty P.M., Bosch J.J., Botto F., Branch K.R.H., Bruns N.C., Cairns J., Carlos Ernesto Peñaherrera, Casanova A., Catanese L., Chen E., Commerford P.J., Connolly S.J., Dagenais G.R., Dans A.M., DeMets D., Deng E., DIaz R., Donato Magno J., Edgar B. Rodas, Eikelboom J.W., Ertl G., Fabbri G., Felix Camilo, Fox K.A.A., Gabizon I., Gosselin G., Goto S., Guzik T.J., Ha J., Halon D., Hart R.G., Heldmann M., Hori M., Kakkar A.K., Keltai K., Keltai M., Kim J.H., Lamelas P.M., Lamy A., Lanas F., Lauw M., Leong D.P., Leong Y., Lewis B.S., Liang D., Liang Y., Liu L., Lonn E.M., Lutay Y., Maggioni A.P., Maly M., María José Paucar, Metsarinne K.P., Mikulik R., Misselwitz F., Moayyedi P., Momomura S.I., Nayar S., Ng K., O’Donnell M., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Perera K., Piegas L.S., Pirvu O., Pogosova N., Prins M., Probstfield J.L., Ramsay T., Ronner E., Rouleau J.L., Rydén L.E., Sato S., Schumi J., Sharma M., Shestakovska O., Shirley Guamán, Silvia Cáceres, Sleight P., Smyth A., Sokolova E., Steg P.G., Stoerk S., Störk S., Thabane L., Tonkin A.M., Torp-Pedersen C., Varigos J.D., Verhamme P.B., Vinereanu D., Widimsky P., Wiendl M., Winkelmann B., Yan Duarte, Yang X., Yufereva Y., Yusoff K., Yusuf S., Zhu J.Fuentes:scopus